Localized Breast Cancer

Oncology·MeSH: Breast Neoplasms

Prevalence

287.0 / 100K

Incidence

128.0 / 100K/yr

3 drugs in development·1 company·1 clinical trial

Drug Pipeline by Phase

Phase 3(2)

Drug	Company
Investigator's selection of appropriate chemotherapy regimen	Filana Therapeutics Inc. (FLNA)
standard neoadjuvant chemotherapy regimens	Filana Therapeutics Inc. (FLNA)

Phase 2(1)

Drug	Company
High Dose Interleukin-2	Filana Therapeutics Inc. (FLNA)

BioSniper tracks 3 drugs in development for Localized Breast Cancer across 1 company.

There are 1 clinical trial targeting Localized Breast Cancer tracked by BioSniper.

The estimated prevalence of Localized Breast Cancer is approximately 287.0 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.